Hemic and Lymphatic Diseases: News and Research on Hemorrhagic Disorders

MeSH tree: C15.378.463

Established cancer drug can reactivate immunotherapy

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...

page 1 from 27